Basics Bicara Therapeutics Inc. Common Stock IPO Date: September 13, 2024 Sector: Healthcare Industry: Biotech Market Cap: $997.03M Activated in VL: True Average Daily Range Avg Daily Range: $0.57 | 3.79% Avg Daily Range (30 D): $0.55 | 3.35% Avg Daily Range (90 D): $0.46 | 3.25% Institutional Daily Volume Avg Daily Volume: .48M Avg Daily Volume (30 D): .57M Avg Daily Volume (90 D): .47M Trade Size Avg Trade Size (Sh.): 75 Avg Trade Size (Sh.) (30 D): 70 Avg Trade Size (Sh.) (90 D): 63 Institutional Trades Total Inst.Trades: 325 Avg Inst. Trade: $1.42M Avg Inst. Trade (30 D): $1.43M Avg Inst. Trade (90 D): $1.23M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.41M Avg Closing Trade (30 D): $.9M Avg Closing Trade (90 D): $1M Avg Closing Volume: 100.83K     News Dec 6, 2025 @ 1:00 PM Bicara Therapeutics’ Preliminary Phase 1b E... Source: Bicara Therapeutics Oct 27, 2025 @ 12:30 PM Nanomedicine Breakthrough Technology Redefining Dr... Source: Prnewswire Jun 1, 2025 @ 5:12 PM Bicara Therapeutics Demonstrates Deep and Durable ... Source: N/A May 22, 2025 @ 9:00 PM Bicara Therapeutics Announces Publication of an Ab... Source: N/A Apr 23, 2025 @ 2:00 PM Bicara Therapeutics to Present Updated Data from O... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $5.37 $-.67 $-.5 Diluted EPS $5.37 $-.67 $-.5 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -121.52M $ -36.33M $ -27.39M Operating Income / Loss $ -141.12M $ -40.68M $ -32.02M Cost of Revenue $ $ $ Net Cash Flow $ -349.09M $ -318.04M $ M PE Ratio 3.57